Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 698 | 5,791 | 770 | -10,330 | -4,380 |
| Depreciation Amortization | 2,896 | 1,934 | 851 | 3,530 | 2,660 |
| Accounts payable and accrued liabilities | -159 | -304 | -337 | -433 | N/A |
| Other Working Capital | -3,571 | 1,577 | -3,551 | -3,740 | -690 |
| Other Operating Activity | -129 | 483 | 638 | 23 | -170 |
| Operating Cash Flow | $-265 | $9,481 | $-1,629 | $-10,950 | $-2,580 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -47,500 | 5,000 | 5,000 | -6,436 | N/A |
| PPE Investments | -2,520 | -1,777 | -876 | -18,490 | -17,290 |
| Other Investing Activity | 0 | 0 | 0 | 246 | -6,200 |
| Investing Cash Flow | $-50,020 | $3,223 | $4,124 | $-24,680 | $-23,490 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 150,000 | 150,000 | 150,000 | 10,150 | N/A |
| Debt Repayment | -273 | -181 | -90 | -58 | N/A |
| Common Stock Issued | 356,604 | 15,312 | 7,645 | 14,784 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -6 | 12,520 |
| Financing Cash Flow | $506,331 | $165,131 | $157,555 | $24,870 | $12,520 |
| Beginning Cash Position | 17,138 | 17,138 | 17,138 | 27,900 | 27,900 |
| End Cash Position | 473,184 | 194,973 | 177,188 | 17,130 | 14,340 |
| Net Cash Flow | $456,046 | $177,835 | $160,050 | $-10,760 | $-13,560 |
| Free Cash Flow | |||||
| Operating Cash Flow | -265 | 9,481 | -1,629 | -10,950 | -2,580 |
| Capital Expenditure | -2,520 | -1,777 | -876 | -18,815 | N/A |
| Free Cash Flow | -2,785 | 7,704 | -2,505 | -29,765 | -2,580 |